Flagship explainer

How Gyre Therapeutics, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$117M · 100%Cost of revenue$5.4M · 5%Gross profit$111M · 95%Operating income$11.5M · 10%Income before tax$14.4M · 12%Income tax$4.6M · 4%Net income$9.9M · 8%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$117M100%
Cost of revenue$5.4M5%
$111M95%
$11.5M10%
Income before tax$14.4M12%
Income tax$4.6M4%
$9.9M8%
Source: · event Dec 31, 2025 · retrieved Oct 15, 2026 · annual-row source set
Embed this chart

View the full Gyre Therapeutics, Inc. analysis at Buy Like Buffett